← Open Payments lookup

AMANDA LANCELEVE: Open Payments

NPI 1053037424 · HAVERHILL, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$464 in 23 payments from 8 companies in 2025. Trend: 2023 $327 · 2024 $778 · 2025 $464

Food & beverage: $464
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.11$157
Teva Pharmaceuticals USA, Inc.3$86
E.R. Squibb & Sons, L.L.C.2$71
Lundbeck LLC3$65
ABBVIE INC.1$24
Indivior Inc.1$23
Otsuka America Pharmaceutical, Inc.1$22
Takeda Pharmaceuticals U.S.A., Inc.1$15

Products named: INGREZZA, REXULTI, COBENFY, UZEDY, AUSTEDO XR, VRAYLAR, SUBLOCADE, TRINTELLIX.

Industry payments across MA — which companies pay providers there.